Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Neutra Corp.
NTRR Signs LOI to Help Create New Topical Cannabis Products
Published Dec 10 2015
4 min read

NTRR Signs LOI to Help Create New Topical Cannabis Products

Moving quickly to capture a share of the rapidly emerging cannabis topicals market, Neutra Corp. (OTCQB:NTRR) announced today that the company signed a letter of intent to partner with a Canadian cannabis company to help market and develop new topical formulas.

The LOI gives NTRR a period of 90 days to conduct due diligence toward a potential joint venture agreement with Vancouver’s Oceanview Health Services Ltd, a new, growth-oriented company focused on natural wellness solutions. If an agreement is reached, the companies will collaborate to deliver cutting-edge topical creams, oils, salves, lotions and more that have been infused with medicinal cannabis for marketing across all of North America’s top cannabis hubs.

“We believe that the cannabis topicals market will experience very strong growth in the coming months and years, and we want to be a part of that growth,” said NTRR CEO Chris Brown. “A potential partnership with Oceanview Health Services would give us the industry access that we need to compete in this emerging cannabis marketplace.”

Many industry watchers attribute cannabis topicals’ rising popularity to their discrete nature and their usefulness in treating a wide variety of health issues, such as bug bites, cuts, bruises, sore muscles, sunburn, arthritis and many more. In the coming year, NTRR plans to unveil many new products to capitalize on the historic growth of the cannabis industry in the U.S., Canada and elsewhere.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB:GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.